PLOS Global Public Health

International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak.

PLOS Global Public Health

Apea V, Titanji BK, Dakin FH, Hayes R, Smuk M, Kawu H, Waters L, Levy I, Kuritzkes DR, Gandhi M, Rockstroh J, Schechter M, Holt M, Palich R, Cortes CP, Nozza S, Mussini C, Calmy A, Crabtree-Ramirez BE, Blanco JL, Bhagani S, Dewsnap C, Orkin C, Mpox SHARE-NET Writing Group

The accuracy of point-of-care C-Reactive Protein as a screening test for tuberculosis in children.

PLOS Global Public Health

Kagujje M, Nyangu S, Maimbolwa MM, Shuma B, Sanjase N, Chungu C, Kerkhoff AD, Creswell J, Muyoyeta M

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.

PLOS Global Public Health

Musinguzi A, Kasidi JR, Kadota JL, Welishe F, Nakitende A, Akello L, Nakimuli J, Kunihira LT, Opira B, Baik Y, Patel D, Sammann A, Berger CA, Aschmann HE, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PPJ, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC, Katahoire AR

Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review.

PLOS Global Public Health

Buis JS, Jerene D, Gebhard A, Bakker R, Majidulla A, Kerkhoff AD, Limaye RJ, Pelzer PT

Exploring HIV risk perception mechanisms among youth in a test-and-treat trial in Kenya and Uganda.

PLOS Global Public Health

Owino L, Johnson-Peretz J, Lee J, Getahun M, Coppock-Pector D, Maeri I, Onyango A, Cohen CR, Bukusi EA, Kabami J, Ayieko J, Petersen M, Kamya MR, Charlebois E, Havlir D, Camlin CS

Participant perspectives on incentives for TB preventative therapy adherence and reduced alcohol use: A qualitative study.

PLOS Global Public Health

Appa A, Miller AP, Fatch R, Kekibiina A, Beesiga B, Adong J, Emenyonu N, Marson K, Getahun M, Kamya M, Muyindike W, McDonell M, Thirumurthy H, Hahn JA, Chamie G, Camlin CS

Feasibility of a social protection linkage program for individuals at-risk for tuberculosis in Uganda.

PLOS Global Public Health

Nanyunja G, Kadota JL, Namale C, Hudson M, Nalugwa T, Turyahabwe S, Cattamanchi A, Katamba A, Muhumuza P, Shete PB

Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study.

PLOS Global Public Health

Namuniina A, Muyanja ES, Biribawa VM, Okech BA, Ssemaganda A, Price MA, Hills N, Nanteza A, Bagaya BS, Weiskopf D, Riou C, Reynolds SJ, Galiwango RM, Redd AD

Pages